Literature DB >> 15962382

Expression of CD44v6 gene in normal human peripheral blood.

Jian Song1, Dong-Sheng Zhang, Jie Zheng.   

Abstract

AIM: To investigate if CD44v6 could be used as a molecular marker of cancer progression and metastasis through the detection of CD44v6 gene expression in normal human peripheral blood.
METHODS: RNA was extracted from the peripheral blood mononuclear cells of 50 healthy donors, the expression of CD44v6 was investigated using reverse transcriptase-polymerase chain reaction (RT-PCR).
RESULTS: CD44v6 mRNA was detected in 58% of healthy volunteers under the proper controls.
CONCLUSION: Our results suggest that the measurement of CD44v6 expression in peripheral blood by RT-PCR is not suitable for detection of circulating tumor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962382      PMCID: PMC4315968          DOI: 10.3748/wjg.v11.i23.3591

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  13 in total

1.  CD44v6 cell surface expression is a common feature of macrophages and macrophage-like cells - implication for a natural macrophage extravasation mechanism mimicked by tumor cells.

Authors:  H Braumüller; S Gansauge; M Ramadani; F Gansauge
Journal:  FEBS Lett       Date:  2000-07-07       Impact factor: 4.124

2.  Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.

Authors:  Gary N Stokes; Jack B Shelton; Christopher M Zahn; Brian S Kendall
Journal:  Gynecol Oncol       Date:  2002-01       Impact factor: 5.482

3.  Expression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation.

Authors:  X Fan; A Long; M Goggins; X Fan; P W Keeling; D Kelleher
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

4.  Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis.

Authors:  Akio Yamaguchi; Takanori Goi; Jiren Yu; Yasuo Hirono; Makoto Ishida; Atsushi Iida; Toshihisa Kimura; Kazuo Takeuchi; Kanji Katayama; Kazuo Hirose
Journal:  J Surg Oncol       Date:  2002-04       Impact factor: 3.454

5.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

Authors:  U Günthert; M Hofmann; W Rudy; S Reber; M Zöller; I Haussmann; S Matzku; A Wenzel; H Ponta; P Herrlich
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

6.  Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3.

Authors:  Andrew P Barbour; Jennifer A Reeder; Michael D Walsh; Jonathan Fawcett; Toni M Antalis; David C Gotley
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

7.  Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.

Authors:  J A Reeder; D C Gotley; M D Walsh; J Fawcett; T M Antalis
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

8.  Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression.

Authors:  H Schrewe; J Thompson; M Bona; L J Hefta; A Maruya; M Hassauer; J E Shively; S von Kleist; W Zimmermann
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

9.  Cytosol concentrations of CD44 isoforms in breast cancer tissue.

Authors:  L Hefler; C Tempfer; G Haeusler; E Kucera; K Mayerhofer; R Zeillinger; A Reinthaller; C Kainz
Journal:  Int J Cancer       Date:  1998-10-23       Impact factor: 7.396

10.  Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors.

Authors:  S Goodison; K Yoshida; T Sugino; A Woodman; H Gorham; J Bolodeoku; M Kaufmann; D Tarin
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.